Farapulse Advent Study

Recruiting

99 years and younger

All

Phase N/A

1 Location

Brief description of study

This investigation is a prospective, randomized, multi-center IDE pivotal study comparing the FARAPULSE Pulsed Field Ablation System to standard of care RF and cryoballoon ablation in subjects with drug-resistant symptomatic PAF. Subjects with documented drug-resistant (Class I-IV) PAF who have had 2 PAF episodes within 12 months of enrollment will undergo percutaneous endocardial ablation for pulmonary vein isolation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Medical Research
Age: - 99 Years
Gender: All

TBD

Updated on 09 Mar 2024. Study ID: 844275

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).